Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease

Pediatr Cardiol. 2014 Jan;35(1):140-8. doi: 10.1007/s00246-013-0752-y. Epub 2013 Jul 31.

Abstract

Continued advancements in congenital cardiac catheterization and interventions have resulted in increased patient and procedural complexity. Anticipation of life-threatening events and required rescue measures is a critical component to preprocedural preparation. We sought to determine the incidence and nature of life-threatening adverse events in congenital and pediatric cardiac catheterization, risk factors, and resources necessary to anticipate and manage events. Data from 8905 cases performed at the 8 participating institutions of the Congenital Cardiac Catheterization Project on Outcomes were captured between 2007 and 2010 [median 1,095/site (range 133-3,802)]. The incidence of all life-threatening events was 2.1 % [95 % confidence interval (CI) 1.8-2.4 %], whereas mortality was 0.28 % (95 % CI 0.18-0.41 %). Fifty-seven life-threatening events required cardiopulmonary resuscitation, whereas 9 % required extracorporeal membrane oxygenation. Use of a risk adjustment model showed that age <1 year [odd ratio (OR) 1.9, 95 % CI 1.4-2.7, p < 0.001], hemodynamic vulnerability (OR 1.6, 95 % CI 1.1-2.3, p < 0.01), and procedure risk (category 3: OR 2.3, 95 % CI 1.3-4.1; category 4: OR 4.2, 95 % CI 2.4-7.4) were predictors of life-threatening events. Using this model, standardized life-threatening event ratios were calculated, thus showing that one institution had a life-threatening event rate greater than expected. Congenital cardiac catheterization and intervention can be performed safely with a low rate of life-threatening events and mortality; preprocedural evaluation of risk may optimize preparation of emergency rescue and bailout procedures. Risk predictors (age < 1, hemodynamic vulnerability, and procedure risk category) can enhance preprocedural patient risk stratification and planning.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Cardiac Catheterization* / adverse effects
  • Cardiac Catheterization* / methods
  • Cardiac Catheterization* / statistics & numerical data
  • Child
  • Child, Preschool
  • Critical Care / methods
  • Critical Care / standards
  • Critical Illness / epidemiology
  • Critical Illness / therapy
  • Disease Management
  • Extracorporeal Membrane Oxygenation* / methods
  • Extracorporeal Membrane Oxygenation* / statistics & numerical data
  • Female
  • Heart Defects, Congenital* / classification
  • Heart Defects, Congenital* / mortality
  • Heart Defects, Congenital* / physiopathology
  • Heart Defects, Congenital* / surgery
  • Hemodynamics
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Intraoperative Complications* / classification
  • Intraoperative Complications* / epidemiology
  • Intraoperative Complications* / physiopathology
  • Intraoperative Complications* / therapy
  • Male
  • Outcome Assessment, Health Care
  • Prospective Studies
  • Quality Improvement
  • Risk Adjustment / methods
  • Risk Factors
  • Safety Management / organization & administration*
  • Severity of Illness Index
  • United States / epidemiology